nutch_noindex
CANCELAR
/nutch_noindex

Sumit Bhargava, MD

  • Sumit Bhargava
  • “I am focused on the well-being of the entire family.”

My parents are famous physicians in Delhi. I watched them treat families in a very warm and open way. That's how I try to be when I see patients in my clinic; I treat patients like I would like to be treated in a doctor's office.

I'm a pediatric pulmonologist and a pediatric sleep medicine doctor. In my sleep practice, I look at children who have sleep disturbances from chronic disease, and physical and mental health issues. I focus on the detection, treatment and prevention of sleep disorders in a variety of different pediatric diseases. I also help to diagnose and treat children with a variety of pulmonary disease.

I want patients and families to know they can look forward to a relationship with me that is based on open communication, mutual trust and respect. I'm a professional, but I strive to be compassionate and empathetic, even in stressful situations. I care about the impact of the illness on the child and the family's life. I try to focus on the well-being of the entire family, as they deal with the illness of their child.

Especialidades

Pulmonary

Trabajo y Educación

Formación Profesional

PtBD Sharma Post Graduate Institute of Medical Education and Research, Rohtak, Haryana, India, 1993

Residencia

University of Kansas School of Medicine, Kansas City, KS, 1998

Compañerismo

Children's Hospital of Philadelphia, Philadelphia, PA, 2001

Certificaciones Médicas

Pediatric Pulmonary, American Board of Pediatrics

Sleep Medicine, American Board of Pediatrics

Condiciones Tratadas

Asthma

Bronchiectasis

Bronchopulmonary Dysplasia

Chronic Cough

Chronic Lung Disease in Infancy

Chronic Ventilator Management

Ciliary Dyskinesias

Congenital Lung Disease

Cystic Fibrosis

Interstitial Lung Disease

Laryngomalacia

Neuromuscular Disease

Pneumonia

Pulmonary Hypertension

Pulmonary Vascular Disease

Sleep Disorders

Sleep Medicine

Tracheomalacia

Todo Publicaciones

Continued Presence of Period Limb Movements During REM Sleep in Patients With Chronic Static Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine Santoro, J. D., Frankovich, J., Bhargava, S. 2018; 14 (7): 118792

Abstract

STUDY OBJECTIVES: A major component of pediatric acute-onset neuropsychiatric syndrome (PANS) is disruption of sleep. These disturbances have been reported in the acute phase of diagnosis but it is unknown if these sleep disruptions persist, especially in patients with chronic static symptoms. This retrospective chart review sought to review polysomnography (PSG) tests of patients in whom PANS has been clinically diagnosed in order to assess sleep architecture, periodic limb movements, and presence of rapid eye movement (REM) sleep without atonia (RSWA) after a chronic static course of symptoms, which were refractory to immunomodulatory interventions.METHODS: Patients were retrospectively identified through the PANS clinic at our institution and had to have fully completed a PSG study and be younger than 18 years. PSG with video were reviewed and scored based on established criteria.RESULTS: We identified 9 patients who met inclusion criteria. The median time from presentation to PSG was 4 years. This study identified PSG-measured periodic limb movement index (PLMI) > 5 events/h in REM sleep in 7 of 9 patients. Two patients with elevated PLMI also demonstrated RSWA, although neither fit a clinical diagnosis of REM sleep behavior disorder. This cohort also demonstrated increased onset of REM sleep (median 134 minutes), insomnia (median total sleep time of 389 minutes), and decreased sleep efficiency (77%).CONCLUSIONS: This study identifies continued sleep disturbances in patients with refractory PANS symptoms several years after diagnosis and treatment. Continued sleep disturbances after presentation and treatment in patients with chronic static PANS may be a contributing factor in prolonged symptomatology of this disease process.

View details for DOI 10.5664/jcsm.7222

View details for PubMedID 29991427

Sleep medicine: pediatric polysomnography revisited CURRENT OPINION IN PEDIATRICS Cornfield, D. N., Bhargava, S. 2015; 27 (3): 325-328

Abstract

Sleep medicine is an increasingly well subscribed component of pediatric medicine. While knowledge has increased significantly in the past five decades, whether the most widely used tool to assess sleep-disordered breathing possesses demonstrable clinical utility remains unknown. The absence of certainty surrounding the impact of polysomnography (PSG) testing on clinical outcomes, superimposed on the cost and inconvenience of PSG testing, prompts a call to reassess the current normative stance toward PSG testing.The present study argues for the use of the following: endpoints that have known clinical significance; readily available data provided by parents; and data derived from a randomized, placebo-controlled trial to determine the merits of PSG testing in the context of obstructive sleep apnea.By rationalizing the use PSG testing, cost, inconvenience, and parental anxiety can be decreased without compromising care.

View details for DOI 10.1097/MOP.0000000000000219

View details for Web of Science ID 000354214800010

View details for PubMedID 25944311

Pulmonary nocardiosis in an immunocompetent patient with cystic fibrosis. Case reports in pulmonology Schoen, L., Santoro, J. D., Milla, C., Bhargava, S. 2015; 2015: 984171-?

Abstract

Nocardia spp. are bacteria of low virulence that cause infection classically in immunocompromised hosts with the lungs as the primary site of infection in the majority of cases. Patients with cystic fibrosis have pulmonary disease characterized by frequent and progressive bacterial infections. Reports of Nocardia spp. isolation in CF are rare in the literature and may represent colonization or active infection, the significance and optimal treatment of which are unknown. We report the second case to date of Nocardia transvalensis pulmonary infection in an immunocompetent patient with CF and the first in a child under the age of eighteen.

View details for DOI 10.1155/2015/984171

View details for PubMedID 25960909